Toni WEINSCHENK,Jens FRITSCHE,Steffen WALTER,Peter LEWANDROWSKI,Harpreet SINGH
申请号：
HK16114573.8
公开号：
HK1226297A
申请日:
2013.07.10
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 95 novel peptide sequences and their variants derived from HLA class I molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
